Related Experiment Video
Updated: Jul 6, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Correlation between rises in Chlamydia pneumoniae-specific antibodies, platelet activation and lipid peroxidation
H Kälvegren1, J Fridfeldt, P Garvin
1Department of Medicine and Health, Faculty of Health Sciences, Linköping University, 581 85, Linköping, Sweden. hanka@imv.liu.se
Insights
Percutaneous coronary intervention (PCI) may release Chlamydia pneumoniae from atherosclerotic lesions, activating platelets and causing lipid peroxidation. This study investigated the link between PCI, C. pneumoniae infection, and cardiovascular risk markers.
Area of Science:
- Cardiovascular Medicine
- Infectious Diseases
- Biochemistry
Background:
- Chlamydia pneumoniae (C. pneumoniae) is known to activate platelets and oxidize low-density lipoproteins in vitro.
- The potential release of C. pneumoniae during percutaneous coronary intervention (PCI) and its subsequent effects on platelet activation and lipid peroxidation remain under investigation.
Purpose of the Study:
- To determine if C. pneumoniae is released during PCI.
- To investigate the association between C. pneumoniae release, platelet activation, and lipid peroxidation following PCI.
Main Methods:
- Serum C. pneumoniae IgA and IgG antibodies, serotonin, and lipid peroxidation were measured in 73 patients undergoing PCI/CABG and 57 controls.
- Measurements were taken before and at 24 hours, 1 month, and 6 months after angiography.
Main Results:
- Patients undergoing PCI/CABG showed significantly higher serum C. pneumoniae IgA concentrations than controls.
- In 38% of C. pneumoniae IgG-positive patients, IgG levels increased 1 month post-PCI.
- Elevated C. pneumoniae IgG 1 month post-PCI correlated strongly with increased plasma lipid peroxidation (r=0.91) and platelet-derived serotonin (r=0.62).
Conclusions:
- PCI treatment for coronary stenosis appears to release C. pneumoniae from atherosclerotic lesions.
- This release is associated with subsequent platelet activation and lipid peroxidation, suggesting a potential mechanism for cardiovascular events post-PCI.
Abstract:
We recently showed that Chlamydia pneumoniae activates platelets in vitro, with an associated oxidation of low-density lipoproteins. The aim of this study was to investigate whether C. pneumoniae is released during percutaneous coronary intervention (PCI) and, thereby, causes platelet activation and lipid peroxidation. Seventy-three patients undergoing coronary angiography and following PCI or coronary artery bypass graft (CABG) and 57 controls were included in the study. C. pneumoniae antibodies, serotonin and lipid peroxidation were measured before and 24 h, 1 month and 6 months after angiography. The results show that serum C. pneumoniae IgA concentrations were significantly higher in patients than in the controls. Furthermore, in 38% of the C. pneumoniae IgG positive patients, the C. pneumoniae IgG concentration increased 1 month after PCI. The levels of C. pneumoniae IgG antibodies 1 month after PCI correlated with plasma-lipid peroxidation (r = 0.91, P < 0.0001) and platelet-derived serotonin (r = 0.62, P = 0.02). There was no elevation in the total serum IgG 1 month after PCI. In conclusion, the present results suggest that PCI treatment of coronary stenosis releases C. pneumoniae from the atherosclerotic lesions, which leads to platelet activation and lipid peroxidation.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...